INDIA, Dec. 3 -- The shares of this leading pharma company engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs) are in focus after announcing a significant capex. In this article, we will dive more into the details of it.

With a market capitalisation of Rs 4,29,409 crore, the shares of Sun Pharmaceutical Industries Ltd made a day high of Rs 1,815.95 per share, up 1 percent from its previous day's closing price of Rs 1,798.05 per share. Over the past five years, the stock has delivered a return of 214 percent, outperforming NIFTY 50's return of 96 percent.

stock exchange filing, announced that its wholly owned subsidiary has given the gree...